Anticorps Recombinant de lapin anti-IGSF8/CD316
IGSF8/CD316 Recombinant Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
FC
Conjugaison
Non conjugué
CloneNo.
243019D8
N° de cat : 98530-2-RR
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en cytométrie | human peripheral whole blood cells, Transfected CHO cells |
Dilution recommandée
| Application | Dilution |
|---|---|
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
98530-2-RR cible IGSF8/CD316 dans les applications de FC et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | IGSF8/CD316 Protéine recombinante Eg2664 |
| Nom complet | immunoglobulin superfamily, member 8 |
| Masse moléculaire calculée | 65 kDa |
| Numéro d’acquisition GenBank | NM_052868.6 |
| Symbole du gène | IGSF8 |
| Identification du gène (NCBI) | 93185 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS with 0.09% sodium azide |
| Conditions de stockage | Store at 2 - 8°C. Stable for one year after shipment. |
Informations générales
IGSF8 is also known as CD316, PGRL (PG regulatory-like protein), KAI/CD82-associated surface molecule, and CD81-binding partner 3 (CD81P3). IGSF8 contains four immunoglobulin domains, a transmembrane region, and a short cytoplasmic tail that does not bear any signature motif for signal transduction. IGSF8 is abundantly expressed in olfactory sensory neuron (OSN) axons and their developing synapses. (PMID: 17785435, PMID: 22687584)
Protocole
| Product Specific Protocols | |
|---|---|
| FC protocol for IGSF8/CD316 antibody 98530-2-RR | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |


